Biomed 101An agent binding to the leukotriene B4 receptor, leading to reduced interleukin-2 mediated hypoxia. Biomed 101 does not affect interleukin-2 antitumor activity.Check for active clinical trials using this agentView this agent in the NCI ThesaurusSearch NCI's Drug DictionaryStarts withContainsPlease enter up to 30 characters for your searchBrowse:ABCDEFGHIJKLMNOPQRSTUVWXYZ#
